Novonesis Invests in TurtleTree to Scale Up Cow-Free Lactoferrin for Early Nutrition
4 Articles
4 Articles
Novonesis Invests in TurtleTree to Scale Up Cow-Free Lactoferrin for Early Nutrition
5 Mins Read Danish biotech giant Novonesis has signed an exclusive deal to scale up and commercialise TurtleTree’s precision-fermented lactoferrin protein, following investment in the Singaporean startup. Singapore’s TurtleTree has taken a giant leap in its effort to bring its cow-free lactoferrin protein to the masses. A year after securing a ’no questions’ letter from the US Food and Drug Administration, the precision fermentation startup has …
TurtleTree, Novonesis strike partnership to scale up precision-fermented lactoferrin
Biotech startup TurtleTree and biosolutions giant Novonesis have struck an agreement to scale the former’s precision fermentation platform, starting with its lactoferrin product. The partnership includes a minority investment into TurtleTree on the part of Novonesis. Financial terms of the deal, which also included participation from 321Catalyst Ventures, the corporate venture capital arm of Mitsui Chemicals, are undisclosed at this time. US- an…
Coverage Details
Bias Distribution
- 100% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium

